⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Anil DesaiM.D.

Internal Medicine · Hackensack, NJ 07601

NPI: 1093102006

Share:

43

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers95th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

730

Total Claims

$63K

Drug Cost

95

Beneficiaries

$659

Cost/Patient

Risk Score Breakdown 43/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+10
Long-acting opioid rate+8

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+2079%

Opioid rate vs peers

48.8% vs 2.2% avg

-53%

Cost per patient vs peers

$659 vs $1,411 avg

-23%

Brand preference vs peers

8.2% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 2,079% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

48.8%

Opioid Rate

356

Opioid Claims

$51K

Opioid Cost

30.3%

Long-Acting Rate

This provider's opioid prescribing rate of 48.8% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

92% generic

Brand: 60 claims · $41K

Generic: 670 claims · $22K

Patient Profile

67

Avg Age

52%

Female

3.96

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About